Cargando…
The Changing Face of Spondyloarthropathies Under TNF α Blockade
OBJECTIVES: Tumor necrosis factor alpha (TNF-α ) therapy has been implicated in the development of autoimmune diseases. Our aim was to describe three patients with spondyloarthropathies who responded to infliximab, a chimeric monoclonal antibody specific for TNF-α but developed new symptoms of spond...
Autores principales: | Elkayam, Ori, Litinsky, Irena, Levartovsky, David, Caspi, Dan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588090/ https://www.ncbi.nlm.nih.gov/pubmed/19088872 http://dx.doi.org/10.2174/1874312900802010053 |
Ejemplares similares
-
Simvastatin Induces Apoptosis of Fibroblast-Like Synoviocytes
por: Litinsky, Ira, et al.
Publicado: (2009) -
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
por: Germano, Valentina, et al.
Publicado: (2014) -
Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2021) -
Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases
por: Laganà, Bruno, et al.
Publicado: (2019) -
Expanding the armamentarium for the spondyloarthropathies
por: Peloso, Paul M, et al.
Publicado: (2004)